FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD

2019

1. 'One for all' configuration: Single left coronary artery with origin of the right coronary artery from the septal branch

   Coronary Artery Disease

2. Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative. Response

   Revista Espanola de Cardiologia

3. Are the management objectives for hospital physicians ethical?

   Revista Clinica Espanola

4. Asymptomatic severe aortic stenosis: biomarkers are welcome

   Heart

5. Behavioral and Psychologic Symptoms in Patients With Pulmonary Hypertension: A Response to Doğan et al.

   Psychosomatics

6. Can Sacubitril/Valsartan Have a Proarrhythmic Effect in Some High-Risk Patients?

   Cardiology (Switzerland)

7. Clinical Characterization of Immunotherapy-Related Pruritus among Patients Seen in 2 Oncodermatology Clinics

   JAMA Dermatology

8. Clinical Profile and Ventricular Arrhythmias after Sacubitril/Valsartan Initiation

   Cardiology (Switzerland)

9. Commentary on "evaluation of Patients for Zika Virus Infection in a Travel Clinic in the Southeast United States, 2016"

   Southern Medical Journal

10. Comparison of machine learning algorithms for clinical event prediction (risk of coronary heart disease)

    Journal of Biomedical Informatics

11. Corrigendum: Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis (Annals of Oncology (2012) 23 (1130-1137) DOI: 10.1093/annonc/mdr432)

    Annals of Oncology

12. Corrigendum: Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab (Annals of Oncology (2017) 28 (761-768) DOI: 10.1093/annonc/mdw695)

    Annals of Oncology

13. Corrigendum: Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer (Annals of Oncology (2014) 25 (592–598) DOI: 10.1093/annonc/mdt543)

    Annals of Oncology

14. Corrigendum: Phase i safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors (Annals of Oncology (2012) 23 (463–471) (DOI: 10.1093/annonc/mdr137)

    Annals of Oncology

15. Corrigendum: Transitive inference remains despite overtraining on premise pair C+D- [Front. Psychol, 9 (2018) (1791-1791)] doi: 10.3389/fpsyg.2018.01791

    Frontiers in Psychology

16. Corrigendum: Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors (Annals of Oncology (2012) 23 (897-902) (DOI: 10.1093/annonc/mdr348)

    Annals of Oncology

17. Cryosurgical management of basal cell carcinoma: in vivo follow-up using reflectance confocal microscopy

    International Journal of Dermatology

18. Effect of liraglutide on cardiovascular outcomes in elderly patients: A post hoc analysis of a randomized controlled trial

    Annals of Internal Medicine

19. Electroanatomical delimitation of recipient atrium in heart transplantation

    Europace

20. Epicardial ablation for ventricular tachycardia in Freidreich's ataxia cardiomyopathy

    Europace